About this trial
The aim of this study is to investigate the effects of expiratory muscle strength training in addition to pelvic floor muscle training in women with stress urinary incontinence. In this study, women will be randomly assigned to one of two separate intervention groups. One group is the Pelvic Floor Muscle Training (PFMT) group, and the other is the PFMT plus Expiratory Muscle Strength Training group. The intervention program will last 8 weeks in both groups. Women in both groups will be evaluated at the beginning of the study (before the interventions) and at the end of the 8th week of intervention. After being taught the exercises included in the PFMT program, both groups will be asked to perform these exercises as a home program. The accuracy of the exercises performed by the women will be checked at two-week intervals, and the number of exercises will be increased. The primary outcome measure is the International Incontinence Consultation Questionnaire-Short Form (ICIQ-UI SF), which measures the Subjective Severity of Incontinence and its Impact on Daily Living.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Women aged 18-65 with SUI
Disqualifiers
Presence of neurological disease
Neurogenic bladder findings,
Pregnancy,
Presence of malignancy,
Trial design
Parallel
Treatments tested in this trial
Pelvic Floor Muscle Training
BehavioralAs part of the PTKE program, women will be taught rapid-maximal isolated contractions and multiple-repeated submaximal isolated contractions via vaginal palpation.
Expiratory muscle strength training
BehavioralExpiratory muscle strength training will be done at home 7 days a week, once a day with 25 breaths, and a 1-minute rest cycle after every 5 breaths.
Treatment groups
Trial outcomes
Primary outcomes
International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form
The subjective severity of incontinence and its impact on daily life will be assessed using the International Incontinence Consultation Questionnaire-Short Form (ICIQ-UI SF).
Secondary outcomes
Respiratory Muscle Strength Assessment
Respiratory muscle strength will be measured using a portable measuring device.
Pelvic Floor Muscle Strength
Pelvic floor muscle strength will be assessed using the Modified Oxford Scale.
Objective incontinence severity
Objective severity of incontinence will be assessed using a 1-hour pad test.
Patient Global Change (Improvement) Perception Scale
At the end of treatment, women's perceptions of improvement in their urinary incontinence levels will be evaluated using the "Patient Global Improvement Perception Scale".
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: